Cannabis News and Research

Latest Cannabis News and Research

Men who prefer beer are more likely to be binge or volume drinkers

Just under a third of young Swiss men prefer beer when they drink alcohol, taking in at least two thirds of their alcohol consumption in the form of the beverage. Far fewer (around five percent) prefer wine.

12 Aug 2013

Young Swiss men understand risks of cannabis consumption

91 percent of on average 20-year-old Swiss men drink alcohol, almost half of whom drink six beverages or more in a row and are thus at-risk consumers. 44 percent of Swiss men smoke tobacco, the majority of whom are at-risk consumers - they smoke at least once a day. 36 percent of young adults smoke cannabis, whereby over half are at-risk consumers, using the drug at least twice a week.

29 Jul 2013

Study: Cannabis has no effect in slowing course of progressive multiple sclerosis

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.

24 Jul 2013

GW Pharmaceuticals to expand marketing authorization for Sativex to France

GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that it has submitted an application under the European Mutual Recognition Procedure seeking to expand the marketing authorization for Sativex into France for the treatment of spasticity due to Multiple Sclerosis.

22 Jul 2013

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Researchers from the University of York have demonstrated that the change in cannabis declassification in 2009 has coincided with a significant increase in hospital admissions for cannabis psychosis - rather than the decrease it was intended to produce.

19 Jul 2013

Long-term cannabis use, dopamine and motivation: an interview with Dr Michael Bloomfield, Department of Medicine at Imperial

We classified ‘long-term’ cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that’s used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.

17 Jul 2013

Study finds that long-term cannabis use affects motivation

Long-term cannabis users tend to produce less dopamine, a chemical in the brain linked to motivation, a study has found.

2 Jul 2013

U.S. medical marijuana industry continues to grow as new bill legalizes MMJ in New Hampshire

As Neutra Corp. works to deliver new innovations to the U.S. medical marijuana industry, the market for those innovations continues to grow. Last week, lawmakers passed a bill to make New Hampshire the 19th state to approve medical marijuana prescriptions for patients with chronic or terminal illnesses.

2 Jul 2013

Cannabis users appear to lack motivation

Researchers found that dopamine levels in a part of the brain called the striatum were lower in people who smoke more cannabis and those who began taking the drug at a younger age.

2 Jul 2013

Survey finds at least 20% of Ontario adolescents had TBI in their lifetime

One in five adolescents surveyed in Ontario said they have suffered a traumatic brain injury that left them unconscious for five minutes or required them to be hospitalized overnight, a statistic researchers in Toronto say is much higher than previously thought.

26 Jun 2013

Neutra finalizes LOI with exciting new partner

Neutra Corp., a rapidly-growing provider of all-natural wellness solutions, announced today it has finalized a letter of intent (LOI) with an exciting new partner to grab a share of the exploding $1.7 billion medical marijuana (MMJ) industry.

24 Jun 2013

U.S. MMJ market to quadruple in size over the next five years, predict analysts

Neutra Corp., a provider of all-natural wellness solutions, welcoms a new law passed in Nevada last week allowing medical marijuana patients to obtain their medicine from dispensaries at last.

17 Jun 2013

Neutra's MMJ subsidiary forms joint venture to market, develop cannabis delivery systems

In a major step forward in its plans to deliver healthier, more effective innovations to the fast-growing medical marijuana industry in the U.S., Neutra Corp. announced today that its MMJ subsidiary, Cannabis Technologies, Inc., has formed a new joint venture with Field of View Technologies, LLC, to market and develop breakthrough cannabis delivery systems.

5 Jun 2013

Extremely low doses of THC protect the brain from long-term cognitive damage

Though marijuana is a well-known recreational drug, extensive scientific research has been conducted on the therapeutic properties of marijuana in the last decade. Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms.

31 May 2013

First alcoholic drink during puberty increases risk of alcohol problems

Research shows that the earlier the age at which youth take their first alcoholic drink, the greater the risk of developing alcohol problems. Thus, age at first drink (AFD) is generally considered a powerful predictor of progression to alcohol-related harm.

18 May 2013

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant, even after excluding patients with a diagnosis of diabetes mellitus. Their findings are reported in the current issue of The American Journal of Medicine.

15 May 2013

Neutra in final stages of negotiations toward new partnership in U.S. MMJ industry

Neutra Corp., a growing provider of all-natural wellness solutions, announced today that it has entered the final stages of negotiations toward a potentially lucrative new partnership in the $1.7 billion U.S. medical marijuana industry.

14 May 2013

Researchers discover connection between CB1 receptors and PTSD

In a first-of-its-kind effort to illuminate the biochemical impact of trauma, researchers at NYU Langone Medical Center have discovered a connection between the quantity of cannabinoid receptors in the human brain, known as CB1 receptors, and post-traumatic stress disorder, the chronic, disabling condition that can plague trauma victims with flashbacks, nightmares and emotional instability.

14 May 2013

New bill could open up new territory for MMJ innovations

As Neutra Corp. works to deliver new innovations making medical marijuana safer and more effective than ever before, the market for such breakthroughs is expanding rapidly. Just last month, two new state legislatures—Pennsylvania and Alabama—saw favorable cannabis bills formally introduced.

8 May 2013

Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

HIV, the virus that causes AIDS, is notorious for hiding within certain types of cells, where it reproduces at a slowed rate and eventually gives rise to chronic inflammation, despite drug therapy.

2 May 2013

Cannabis News and Research

Latest Cannabis News and Research

Men who prefer beer are more likely to be binge or volume drinkers

Young Swiss men understand risks of cannabis consumption

Study: Cannabis has no effect in slowing course of progressive multiple sclerosis

GW Pharmaceuticals to expand marketing authorization for Sativex to France

Study shows link between reclassification of cannabis, hospital admissions for cannabis psychosis

Long-term cannabis use, dopamine and motivation: an interview with Dr Michael Bloomfield, Department of Medicine at Imperial

Study finds that long-term cannabis use affects motivation

U.S. medical marijuana industry continues to grow as new bill legalizes MMJ in New Hampshire

Cannabis users appear to lack motivation

Survey finds at least 20% of Ontario adolescents had TBI in their lifetime

Neutra finalizes LOI with exciting new partner

U.S. MMJ market to quadruple in size over the next five years, predict analysts

Neutra's MMJ subsidiary forms joint venture to market, develop cannabis delivery systems

Extremely low doses of THC protect the brain from long-term cognitive damage

First alcoholic drink during puberty increases risk of alcohol problems

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Neutra in final stages of negotiations toward new partnership in U.S. MMJ industry

Researchers discover connection between CB1 receptors and PTSD

New bill could open up new territory for MMJ innovations

Synthetic anti-inflammatory substances related to marijuana may help fight HIV infection

Pittcon Highlights: Cannabis & Psychedelics eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production